Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 8, 2006, Pages 1188-1192

  Jiménez Heffernan, José A ^a,d   Bajo, M Auxiliadora ^b,d   Perna, Cristian ^a,d   Del Peso, Gloria ^b,d   Larrubia, Juan R ^a,d   Gamallo, Carlos ^c,d   Sánchez Tomero, José A ^c,d   López Cabrera, Manuel ^c,d   Selgas, Rafael ^b,d  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Section of Nephrology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; BACTERIAL IMMUNITY; BLOOD CELL COUNT; CELL LOSS; CLINICAL ARTICLE; EVALUATION RESEARCH; FEMALE; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INGUINAL HERNIA; MALE; MESOTHELIUM CELL; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEUM MAST CELL; PERITONITIS; QUANTITATIVE ASSAY; UREMIA; VASCULAR DISEASE;

EID: 33746754132     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: 10.5858/2006-130-1188-mcqinp     Document Type: Article

References (37)

1. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033-1079.
2. Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2003;111(suppl):486-494.
3. Di Paolo N, Sacchi G. Atlas of peritoneal histology in normal conditions and during peritoneal dialysis. Perit Dial Int. 2000;20(suppl 3):31.
4. Frossi B, De Carli M, Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J Leukoc Biol. 2004;75:579-585.
5. Malaviya R, Abraham SN. Mast cell modulation of immune responses to bacteria. Immunol Rev. 2001;179:16-24.
6. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 1996;381:75-77.
7. Malaviya R, Abraham SN. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol. 2000; 67:841-846.
8. Levi-Schaffer F, Weg VB. Mast cells, eosinophils and fibrosis. Clin Exp Allergy. 1997;27(suppl 1):64-70.
9. Norrby K. Mast cells and angiogenesis. APMIS. 2002;110:355-371.
10. Kondo S, Kagami S, Kido H, Strutz F, Müller CA, Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol. 2001;12:1668-1676.
11. Liebman SM, Langer JC, Monk PK, Pelletier GJ. Mast cells mediators and peritoneal adhesion formation in the rat. J Surg Res. 1995;59:344-348.
12. Roberts IS, Brenchley PE. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol. 2000;53:858-862.
13. Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F. Role of mast cells and myofibroblasts in human peritoneal adhesion formation. Ann Surg. 2002; 236:593-601.
14. Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue I histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med. 2002;195:973-982.
15. Miyazawa S, Hotta O, Doi N, Natori Y, Nishikawa K, Natori Y. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int. 2004;65:2228-2237.
16. Sugihara A, Tsujimura T, Fujita Y, Nakata Y, Terrada N. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol. 1999;30:859-867.
17. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003;23:530-541.
18. Hekking LH, Zareie M, Driesprong BAJ, et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol. 2001;12:2775-2786.
19. Zareie M, Hekking LHP, Driesprong BAJ, ter Wee PM, Beelen RHJ, van den Born J. Accumulation of omental mast cells during peritoneal dialysis. Perit Dial Int. 2001;21(suppl 3):373-376.
20. Horny HP, Sillaber C, Menke D, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol. 1998;22:1132-1140.
21. Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int. 2003;23:116-122.
22. Honda K, Nitta K, Horita S, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant. 1999;14:1541-1549.
23. Zareie M, Hekking LH, Welten AG, et al. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol Dial Transplant. 2003;18:2629-2637.
24. Zareie M, De Vriese AS, Hekking LH, et al. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol Dial Transplant. 2005;20: 1350-1361.
25. Beil WJ, Schulz M, Wefelmeyer U. Mast cell granule composition and tissue location: a close correlation. Histol Histopathol. 2000;15:937-946.
26. Wang H-W, Tedla N, Lloyd AR, Wakefield D, McNeil HP. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest. 1998;102:1617-1626.
27. Kolaczkowska E, Shahzidi S, Seljelid R, van Rooijen N, Plytycz B. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation. 2002;26:61-71.
28. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996;381:77-81.
29. Lindstedt KA, Wang Y, Shiota N, et al. Activation of paracrine TGF-β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J. 2001;15:1377-1388.
30. Williams CM, Coleman JW. Induced expression of mRNA for IL-5, IL-6, TNF-, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology. 1995;86: 244-249.
31. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol. 1994;158:253-264.
32. Frandji P, Tkaczyk C, Oskeritzian C, et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/ macrophagecolony-stimulating factor and downregulation by interferon-gamma. Cell Immunol. 1995; 163:37-46.
33. Jippo T, Morii E, Ito A, Kitamura Y. Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice. J Exp Med. 2003;197:1417-1425.
34. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 2003;107:2555-2558.
35. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG. Human mast cells stimulate vascular tube formation: triptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99:2691-2700.
36. Grutzkau A, Kruger-Krasagakes S, Baumesiter H, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEG/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell. 1998;9:875-884.
37. Garosi G, Di Paolo N. Peritoneal sclerosis: one or two nosological entities? Semin Dial. 2000;13:297-308.